Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Edith A Perez

8PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NanomedicineCommunication technology and digital media studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Jun 23, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.

Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta

|Mar 07, 2025
Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer.

Saranya Chumsri, Joseph J Larson, Emily Liu

|Jul 10, 2024
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations.

Hesham Elghazaly, Hamdy A Azim, Hope S Rugo

|Jun 02, 2024
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.

Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta

|Sep 27, 2022
Understanding Modern Medical Centers: Beyond Simone-Intersectional Maxims for a New Era.

Stephanie L Graff, Tanya Wildes, Narjust Duma

|May 19, 2022
Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review.

Edith A Perez, Chau Dang, Caleb Lee

Pageof 2

Frequent Collaborators

2 joint publications

Matthew J Ellis

2 joint publications

Manuela Rabaglio

2 joint publications

George W Sledge

2 joint publications

Karen A Gelmon

2 joint publications

Karen M Winkfield

2 joint publications

James N Ingle

2 joint publications

Vered Stearns

2 joint publications

G Thomas Budd

2 joint publications

Shakeel Virk

2 joint publications

Jane Bayani

Frequent Collaborators

2 joint publications

Matthew J Ellis

2 joint publications

Manuela Rabaglio

2 joint publications

George W Sledge

2 joint publications

Karen A Gelmon

Top Related Videos

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on : Apr 03, 2026

481
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

4.0K
See more related videos

Top Related Videos

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on : Apr 03, 2026

481
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

4.0K
See more related videos